Morgan Stanley Seres Therapeutics, Inc. Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 149,604 shares of MCRB stock, worth $2.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

149,604

Previous 2,013,251 92.57%

Holding current value

$2.11 Million

Previous $1.67 Million 93.77%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.64 - $0.91 $1.19 Million - $1.7 Million	-1,863,647 Reduced 92.57%	149,604 $104,000
Q4 2024 Feb 14, 2025	BUY	$0.55 - $0.98 $666,009 - $1.19 Million	1,210,926 Added 150.93%	2,013,251 $1.67 Million
Q3 2024 May 14, 2025	BUY	$0.7 - $1.48 $441,867 - $934,233	631,239 Added 368.96%	802,325 $762,000
Q3 2024 Nov 14, 2024	BUY	$0.7 - $1.48 $441,867 - $934,233	631,239 Added 368.96%	802,325 $762,000
Q2 2024 May 14, 2025	SELL	$0.56 - $1.19 $1.03 Million - $2.19 Million	-1,842,165 Reduced 91.5%	171,086 $123,000
Q2 2024 Oct 17, 2024	SELL	$0.56 - $1.19 $171,661 - $364,781	-306,539 Reduced 64.18%	171,086 $123,000
Q2 2024 Aug 14, 2024	SELL	$0.56 - $1.19 $171,661 - $364,781	-306,539 Reduced 64.18%	171,086 $123,000
Q1 2024 Oct 17, 2024	BUY	$0.75 - $1.56 $229,904 - $478,200	306,539 Added 179.17%	477,625 $367,000
Q1 2024 Aug 16, 2024	SELL	$0.75 - $1.56 $305,783 - $636,029	-407,711 Reduced 46.05%	477,625 $367,000
Q1 2024 May 15, 2024	SELL	$0.75 - $1.56 $305,783 - $636,029	-407,711 Reduced 46.05%	477,625 $367,000
Q4 2023 Aug 16, 2024	BUY	$0.93 - $2.15 $664,252 - $1.54 Million	714,250 Added 417.48%	885,336 $1.24 Million
Q4 2023 Feb 13, 2024	BUY	$0.93 - $2.15 $479,822 - $1.11 Million	515,938 Added 139.67%	885,336 $1.24 Million
Q3 2023 Nov 15, 2023	SELL	$2.33 - $5.07 $213,828 - $465,284	-91,772 Reduced 19.9%	369,398 $879,000
Q2 2023 Aug 14, 2023	BUY	$4.67 - $6.55 $1.25 Million - $1.75 Million	266,954 Added 137.45%	461,170 $2.21 Million
Q1 2023 May 15, 2023	SELL	$4.95 - $6.09 $122,294 - $150,459	-24,706 Reduced 11.29%	194,216 $1.1 Million
Q4 2022 Feb 14, 2023	BUY	$5.09 - $9.05 $506,694 - $900,900	99,547 Added 83.39%	218,922 $1.23 Million
Q3 2022 Nov 14, 2022	SELL	$3.5 - $7.2 $368,413 - $757,879	-105,261 Reduced 46.86%	119,375 $765,000
Q2 2022 Oct 27, 2022	SELL	$2.7 - $7.62 $1 Million - $2.83 Million	-370,885 Reduced 62.28%	224,636 $770,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.62 $1 Million - $2.83 Million	-370,885 Reduced 62.28%	224,636 $770,000
Q1 2022 Oct 27, 2022	BUY	$6.3 - $8.84 $2.34 Million - $3.28 Million	370,885 Added 165.1%	595,521 $4.24 Million
Q1 2022 May 13, 2022	BUY	$6.3 - $8.84 $320,065 - $449,107	50,804 Added 9.33%	595,521 $4.24 Million
Q4 2021 Feb 14, 2022	SELL	$6.02 - $11.43 $823,042 - $1.56 Million	-136,718 Reduced 20.06%	544,717 $4.54 Million
Q3 2021 Nov 15, 2021	BUY	$5.46 - $22.6 $3.72 Million - $15.4 Million	681,435 New	681,435 $4.74 Million

Others Institutions Holding MCRB

# of Institutions

Shares Held

39.5M

Call Options Held

103K

Put Options Held

53K

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $1.75B
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account